Aignostics raises €14.0M Series A round
15 September 2022· Berlin, Germany· health, biotech, ai, industrial_software, b2b, pure_software
The company plans to use the funds to expand its U.S. market presence and further advance its AI platform, with a focus on GCP-compliant development and clinical trial support.
Investors
LeadWellington Partners
Also participating
High-Tech GründerfondsCarma FundIBB VenturesBoehringer Ingelheim Venture Fund
About Aignostics
Stage
Series B
Headquarters
Berlin, Germany
Founded
2020
Team Size
51–200
Sectors
healthbiotechaiindustrial_softwareb2bpure_software